Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multicenter Observational Study on Recurrence Patterns and Health Care Resource Utilization in Stage II Cutaneous Melanoma in Spain: Real-world Evidence From the METHEOR Study.

Actas dermo-sifiliograficas·2026
Same author

Complete Lymph Node Dissection vs Observation in Patients With Cutaneous Melanoma and Positive Sentinel Lymph Node Biopsy With High-risk Criteria: Multicenter Analysis in Hospitals in the Mediterranean Area.

Actas dermo-sifiliograficas·2026
Same author

Is Neoadjuvancy with Imatinib Useful Before Mohs Surgery in Locally Advanced Dermatofibrosarcoma Protuberans? Experience of a Dermato-Oncology Referral Center.

International journal of molecular sciences·2026
Same author

Patient- and Clinician-reported Outcomes, Safety and Efficacy Profile of Tirbanibulin 1% for Actinic Keratosis Under Conditions Close to Routine Clinical Practice in Spain and Italy (TIRBASKIN Study).

Actas dermo-sifiliograficas·2026
Same author

Clinical, Histopathologic, and Surgical Aspects of Dermatofibrosarcoma Protuberans on the Head vs Other Locations: Retrospective Single-center Case Series of 235 Tumors.

Actas dermo-sifiliograficas·2026
Same author

Cutaneous Melanoma: Association of Histopathological Subtypes and Breslow Thickness With Occupation and Residence in an Observational Study of 2486 Patients.

Actas dermo-sifiliograficas·2026
Same journal

Fingolimod-associated lymphomatoid papulosis.

Actas dermo-sifiliograficas·2026
Same journal

Demodicosis: update and treatment with laser and other light sources.

Actas dermo-sifiliograficas·2026
Same journal

New treatments for adult female acne.

Actas dermo-sifiliograficas·2026
Same journal

First regulations of the Spanish Society of Dermatology (1909).

Actas dermo-sifiliograficas·2026
Same journal

Long-hair FUE: advantages and disadvantages of the most recent technique in hair transplantation.

Actas dermo-sifiliograficas·2026
Same journal

Sunburns, Tanning, and Social Media: A Descriptive Study Among Spanish University Students.

Actas dermo-sifiliograficas·2026
See all related articles

Related Experiment Video

Updated: May 26, 2026

An In Vitro Approach to Photodynamic Therapy
04:53

An In Vitro Approach to Photodynamic Therapy

Published on: August 17, 2018

[Photodynamic therapy vs imiquimod].

C Serra-Guillén1, E Nagore, C Guillén

  • 1Servicio de Dermatología, Instituto Valenciano de Oncología, Valencia, España. cserraguillen@gmail.com

Actas Dermo-Sifiliograficas
|December 20, 2011
PubMed
Summary
This summary is machine-generated.

Photodynamic therapy and imiquimod are common dermatological treatments for skin conditions like actinic keratoses. Comparative evidence is lacking, making it difficult to choose between them for specific lesions or patients.

More Related Videos

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
11:04

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model

Published on: January 13, 2023

Related Experiment Videos

Last Updated: May 26, 2026

An In Vitro Approach to Photodynamic Therapy
04:53

An In Vitro Approach to Photodynamic Therapy

Published on: August 17, 2018

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
11:04

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model

Published on: January 13, 2023

Area of Science:

  • Dermatology
  • Oncology

Background:

  • Photodynamic therapy (PDT) and imiquimod are frequently used by dermatologists for actinic keratoses, basal cell carcinoma, and Bowen disease.
  • Limited comparative trial data hinders definitive conclusions on the efficacy and safety of PDT versus imiquimod.

Purpose of the Study:

  • To critically review and compare photodynamic therapy and imiquimod for specific dermatological conditions.
  • To provide guidance on selecting the more appropriate treatment based on lesion type and patient factors.

Main Methods:

  • Comparative review of existing literature on photodynamic therapy and imiquimod.
  • Analysis of evidence for specific indications, including potentially contraindicated scenarios.

Main Results:

  • Scarcity of comparative trials limits evidence-based recommendations for general use.
  • Evidence supports PDT or imiquimod in specific conditions like actinic cheilitis, immunosuppression, and periocular basal cell carcinoma, even when seemingly contraindicated.

Conclusions:

  • Further comparative studies are needed to establish optimal treatment guidelines for photodynamic therapy and imiquimod.
  • Treatment selection should consider specific clinical scenarios and patient factors, with emerging evidence supporting use in challenging cases.